IONS
USDIonis Pharmaceuticals Inc. Common Stock
Precio en Tiempo Real
Gráfico de Precios
Métricas Clave
Métricas de Mercado
Apertura
$73.790
Máximo
$75.000
Mínimo
$72.360
Volumen
0.79M
Fundamentos de la Empresa
Capitalización de Mercado
11.9B
Industria
Biotecnología
País
United States
Estadísticas de Negociación
Volumen Promedio
2.47M
Bolsa
NMS
Moneda
USD
Rango de 52 Semanas
Noticias Relacionadas
HC Wainwright & Co. Maintains Buy on Ionis Pharmaceuticals, Raises Price Target to $110
HC Wainwright & Co. analyst Mitchell S. Kapoor maintains Ionis Pharmaceuticals with a Buy and raises the price target from $100 to $110.
Piper Sandler Maintains Overweight on Ionis Pharmaceuticals, Raises Price Target to $77
Piper Sandler analyst Allison Bratzel maintains Ionis Pharmaceuticals with a Overweight and raises the price target from $70 to $77.
TD Cowen Maintains Buy on Ionis Pharmaceuticals, Raises Price Target to $99
TD Cowen analyst Yaron Werber maintains Ionis Pharmaceuticals with a Buy and raises the price target from $59 to $99.
Morgan Stanley Maintains Overweight on Ionis Pharmaceuticals, Raises Price Target to $94
Morgan Stanley analyst Michael Ulz maintains Ionis Pharmaceuticals with a Overweight and raises the price target from $90 to $94.
HC Wainwright & Co. Maintains Buy on Ionis Pharmaceuticals, Raises Price Target to $100
HC Wainwright & Co. analyst Mitchell S. Kapoor maintains Ionis Pharmaceuticals with a Buy and raises the price target from $95 to $100.
Barclays Maintains Overweight on Ionis Pharmaceuticals, Raises Price Target to $95
Barclays analyst Gena Wang maintains Ionis Pharmaceuticals with a Overweight and raises the price target from $80 to $95.
RBC Capital Maintains Outperform on Ionis Pharmaceuticals, Raises Price Target to $82
RBC Capital analyst Luca Issi maintains Ionis Pharmaceuticals with a Outperform and raises the price target from $80 to $82.
Acciones Relacionadas
EQS
Equus Total Return Inc.
IOSP
Innospec Inc.
RCL
Royal Caribbean Cruises Ltd.
ROIC
Retail Opportunity Investments Corp. (MD)
HTIA
Healthcare Trust Inc. 7.375% Series A Cumulative Redeemable Perpetual Preferred Stock
Mantente Actualizado
Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.